CA2293008A1 — Premixed alatrofloxacin injectable compositions
Assigned to Pfizer Products Inc · Expires 2000-07-28 · 26y expired
What this patent protects
The present invention provides premixed (ready-to-use) pharmaceutical compositions for intravenous administration containing an aqueous solution of alatrofloxacin or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable tonicity agents. The present invention …
USPTO Abstract
The present invention provides premixed (ready-to-use) pharmaceutical compositions for intravenous administration containing an aqueous solution of alatrofloxacin or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable tonicity agents. The present invention also provides methods of using such compositions to treat or prevent a variety of bacterial infections.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.